Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CDKN1A: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Cell cycle regulator with critical roles in neuronal survival, DNA damage response, and neurodegeneration
No AI portrait yet
| Gene Symbol | CDKN1A |
| Full Name | Cyclin-Dependent Kinase Inhibitor 1A |
| Chromosome | 6p21.31 |
| Function | is a key cell cycle regulator that mediates p53-dependent cell cycle arrest. |
| Amino Acids | 164 aa |
| Pathways | TGF-β |
| UniProt ID | P38936 |
| NCBI Gene ID | 1026 |
| Ensembl ID | ENSG00000100994 |
| GeneCards | CDKN1A |
| Human Protein Atlas | CDKN1A |
| N-terminal domain | binds and inhibits CDK2/cyclin E and CDK1/cyclin B complexes |
| C-terminal domain | interacts with PCNA (proliferating cell nuclear antigen), blocking DNA replication |
| p53-binding region | contains p53-responsive elements for transcriptional activation |
| Neurons | particularly in post-mitotic differentiated neurons |
| Associated Diseases | Aging, Als, Alzheimer, Cancer, Cellular Senescence |
| Known Drugs/Compounds | rapamycin |
| Interactions | ACTB, AGING, AGO2, AKT, AND, APOPTOSIS |
| KG Connections | 470 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
CDKN1A["CDKN1A"] -->|"regulates"| Senescence["Senescence"]
CDKN1A["CDKN1A"] -->|"regulates"| Ms["Ms"]
CDKN1A["CDKN1A"] -->|"regulates"| Autism["Autism"]
CDKN1A["CDKN1A"] -->|"associated"| Als["Als"]
CDKN1A["CDKN1A"] -->|"associated"| Ms_1["Ms"]
CDKN1A["CDKN1A"] -->|"therapeutic target"| Ms_2["Ms"]
CYCS["CYCS"] -.->|"inhibits"| CDKN1A["CDKN1A"]
CD4["CD4"] -->|"interacts"| CDKN1A["CDKN1A"]
MAPK3["MAPK3"] -->|"interacts"| CDKN1A["CDKN1A"]
ZAP70["ZAP70"] -->|"interacts"| CDKN1A["CDKN1A"]
style CDKN1A fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:CDKN1A | data_in | dataset_row | 0.00 |
| benchmark_ot_ad_answer_key:CDKN1A | data_in | dataset_row | 0.00 |
| ds-83b31ef18d49 | provides_data_for | dataset | 1.00 |
| Senescent Cells | expressed_in | cell_type | 0.95 |
| Autophagosome | associated_with | cell_type | 0.90 |
| Cellular Senescence | associated_with | phenotype | 0.90 |
| Alzheimer'S Disease | therapeutic_target | disease | 0.88 |
| Proliferative Arrest | causes | process | 0.85 |
| Proliferative Arrest | inhibits | process | 0.85 |
| Pulmonary Vascular Endothelial Cell Senescence | biomarker_for | process | 0.85 |
| Cellular Senescence | biomarker_for | process | 0.80 |
| Senescence | biomarker_for | process | 0.80 |
| ROS | activates | gene | 0.80 |
| Als | activates | disease | 0.75 |
| Cancer | activates | disease | 0.75 |
| Senescence | regulates | disease | 0.75 |
| Mapk | therapeutic_target | pathway | 0.70 |
| CANCER | activates | gene | 0.70 |
| P62 | regulates | gene | 0.70 |
| GENES | regulates | gene | 0.70 |
| P21 | inhibits | gene | 0.70 |
| Als | expressed_in | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Dementia | expressed_in | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Synucleinopathy | inhibits | disease | 0.65 |
| Aging | therapeutic_target | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | expressed_in | disease | 0.65 |
| Parkinson | inhibits | disease | 0.65 |
| Ataxia | inhibits | disease | 0.65 |
| Senescence | inhibits | disease | 0.65 |
| Senescence | therapeutic_target | disease | 0.65 |
| Ferroptosis | associated_with | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Autism | regulates | disease | 0.65 |
| Hepatitis | associated_with | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Rheumatoid Arthritis | associated_with | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Senescence | associated_with | disease | 0.65 |
| Tumor | associated_with | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Carcinoma | activates | disease | 0.65 |
| Neurodegeneration | inhibits | disease | 0.65 |
| Aging | inhibits | disease | 0.65 |
| Inflammation | inhibits | disease | 0.65 |
| Viral Infection | regulates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:CDKN1A | data_in | dataset_row | 0.00 |
| benchmark_ot_ad_answer_key:CDKN1A | data_in | dataset_row | 0.00 |
| ds-83b31ef18d49 | data_in | dataset | 1.00 |
| SQSTM1 | mediates | protein | 0.95 |
| Mir-302B | targets | biomarker | 0.90 |
| XHP | upregulates | drug | 0.90 |
| MIR-302B | targets | gene | 0.90 |
| Polygonatum Sibiricum Polysaccharide | downregulates | compound | 0.85 |
| SIRT1 | downregulates | protein | 0.85 |
| Autophagy Deficiency | causes | phenotype | 0.85 |
| SQSTM1 | binds_to | gene | 0.80 |
| telomere shortening | upregulates | phenotype | 0.80 |
| Srt2104 | downregulates | drug | 0.80 |
| Xiyangshen Sanqi Danshen Granules | downregulates | drug | 0.80 |
| MIRNAS | regulates | gene | 0.70 |
| P53 | activates | gene | 0.70 |
| MAPK3 | therapeutic_target | gene | 0.70 |
| SYNUCLEINOPATHY | inhibits | gene | 0.60 |
| NF-ΚB | inhibits | gene | 0.60 |
| MICRORNAS | associated_with | gene | 0.60 |
| GENES | therapeutic_target | gene | 0.60 |
| EXOSOMES | therapeutic_target | gene | 0.60 |
| CYCS | inhibits | gene | 0.60 |
| RNA | regulates | gene | 0.60 |
| CCNG2 | inhibits | gene | 0.60 |
| CCND1 | regulates | gene | 0.60 |
| ALS | expressed_in | gene | 0.60 |
| NEURON | expressed_in | gene | 0.60 |
| DEMENTIA | expressed_in | gene | 0.60 |
| FURIN | associated_with | gene | 0.60 |
| CANCER | associated_with | gene | 0.60 |
| P53 | expressed_in | gene | 0.60 |
| DNA | regulates | gene | 0.60 |
| ATG | activates | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| CYTOKINES | inhibits | gene | 0.60 |
| RNA | encodes | gene | 0.60 |
| DNA | encodes | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| ROS | associated_with | gene | 0.60 |
| MTORC1 | regulates | gene | 0.60 |
| rapamycin | targets | drug | 0.60 |
| OXIDATIVE STRESS | activates | gene | 0.60 |
| TPRKB | activates | gene | 0.60 |
| TSC22D3 | regulates | gene | 0.60 |
| NEUROINFLAMMATION | inhibits | gene | 0.60 |
| MIR-302B | inhibits | gene | 0.60 |
| CD4 | interacts_with | gene | 0.60 |
| MAPK3 | interacts_with | gene | 0.60 |
| EXOSOMES | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning CDKN1A in their description or question text
No additional research found